CVS Health Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
CVS Health (CVS) PT Lowered to $76 at Jefferies Following 3Q
November 7, 2017 8:24 AM ESTJefferies lowered its price target on CVS Health (NYSE: CVS) to $76.00 (from $86.00) while maintaining a Hold rating. CVS reported Q3 EPS of $1.50 that beat consensus by $0.02. Similar to the last few quarters, SSS revs were pressured by weakness in front-end sales and the... More
CVS Health (CVS) PT Lowered to $85 at Leerink Partners
November 7, 2017 7:48 AM ESTLeerink Partners lowered its price target on CVS Health (NYSE: CVS) to $85.00 (from $90.00) while maintaining an Outperform rating.
Analyst David Larsen notes volumes starting to show some improvement and the company is responding aggressively to Amazon.
In the quarter same-store... More
CVS Health (CVS) Tops Q3 EPS by 1c; Narrows EPS Outlook, Raising Midpoint
November 6, 2017 6:59 AM ESTCVS Health (NYSE: CVS) reported Q3 EPS of $1.50, $0.01 better than the analyst estimate of $1.49. Revenue for the quarter came in at $46.2 billion versus the consensus estimate of $46.17 billion.
Narrowed and raised the mid-point of the range for full year GAAP diluted EPS from continuing... More